Fundraising Fox

Imara

NASDAQ: ELVN

Cambridge, US · Founded 2016 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

SN
Sara NayeemDirector
BD
Barbara DaltonDirector
DM
David MottDirector
RH
Robert HopfnerDirector
MK
Mette Kirstine AggerDirector
JG
James G. McArthurExecutive Officer, Director
CM
Christoph M. AdamsExecutive Officer, Director

Investors · 3

Bay City CapitalSan Rafael · $5M – $10Mvia Carl Goldfischer · board
RA CapitalBoston
OrbiMedreportedNew York · $1M – $75Mvia David Bonita · board

Reported raises · per SEC filings

Form D private placements
▶$90MraisedApr 2024 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Helen CollinsExecutive Officer
  • Andrew PhillipsDirector
  • Richard HeymanDirector
  • Mika DerynckDirector
  • Benjamin HohlExecutive Officer
  • Anish PatelExecutive Officer
  • Joseph P. LyssikatosExecutive Officer, Director
  • Jake BauerDirector
  • Rahul BallalDirector
  • Rishi GuptaDirector
  • Samuel KintzExecutive Officer, Director
Offering amount
$90M
Amount sold
$90M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$44.1MraisedMar 2019 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David BonitaDirector
  • Christoph M. AdamsExecutive Officer
  • Barbara DaltonDirector
  • James G. McArthurDirector
  • Rahul BallalExecutive Officer, Director
  • David MottDirector
  • Carl GoldfischerDirector
  • Mark ChinDirector
  • Mette Kirstine AggerDirector
  • Sara NayeemDirector
Offering amount
$63M
Amount sold
$44.1M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedApr 2016 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Sara NayeemDirector
  • Barbara DaltonDirector
  • David MottDirector
  • Robert HopfnerDirector
  • Mette Kirstine AggerDirector
  • James G. McArthurExecutive Officer, Director
  • Christoph M. AdamsExecutive Officer, Director
Offering amount
$31M
Amount sold
$6M
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.